136 related articles for article (PubMed ID: 28432106)
1. Prohibitin-induced obesity leads to anovulation and polycystic ovary in mice.
Ande SR; Nguyen KH; Xu YXZ; Mishra S
Biol Open; 2017 Jun; 6(6):825-831. PubMed ID: 28432106
[TBL] [Abstract][Full Text] [Related]
2. Gonadectomy in Mito-Ob mice revealed a sex-dimorphic relationship between prohibitin and sex steroids in adipose tissue biology and glucose homeostasis.
Xu YXZ; Ande SR; Mishra S
Biol Sex Differ; 2018 Aug; 9(1):37. PubMed ID: 30157935
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
4. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
5. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
6. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
7. Involvement of GDF-9, leptin, and IGF1 receptors associated with adipose tissue transplantation on fertility restoration in obese anovulatory mice.
Pereira M; Vidotti DB; Borra RC; Simões Mde J; Da Silva ID; Haidar MA
Gynecol Endocrinol; 2011 Oct; 27(10):759-66. PubMed ID: 21557698
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
9. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
[TBL] [Abstract][Full Text] [Related]
10. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?
van Houten EL; Visser JA
Reprod Biol; 2014 Mar; 14(1):32-43. PubMed ID: 24607253
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
12. Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes.
Layacha SY; Biswas DA
Cureus; 2023 Jan; 15(1):e33390. PubMed ID: 36751233
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
Kurzrock R; Cohen PR
Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
[TBL] [Abstract][Full Text] [Related]
14. Obesity-related abnormalities couple environmental triggers with genetic susceptibility in adult-onset T1D.
Nguyen KH; Ande SR; Mishra S
Biochem Biophys Res Commun; 2016 Jan; 470(1):94-100. PubMed ID: 26766792
[TBL] [Abstract][Full Text] [Related]
15. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
16. Prohibitin - At the crossroads of obesity-linked diabetes and cancer.
Mishra S; Nyomba BG
Exp Biol Med (Maywood); 2017 Jun; 242(11):1170-1177. PubMed ID: 28399645
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
18. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
Pagotto U; Gambineri A; Vicennati V; Heiman ML; Tschöp M; Pasquali R
J Clin Endocrinol Metab; 2002 Dec; 87(12):5625-9. PubMed ID: 12466363
[TBL] [Abstract][Full Text] [Related]
19. High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model.
Roberts JS; Perets RA; Sarfert KS; Bowman JJ; Ozark PA; Whitworth GB; Blythe SN; Toporikova N
Biol Reprod; 2017 Mar; 96(3):551-562. PubMed ID: 28203719
[TBL] [Abstract][Full Text] [Related]
20. Infertility in Female Mice with a Gain-of-Function Mutation in the Luteinizing Hormone Receptor Is Due to Irregular Estrous Cyclicity, Anovulation, Hormonal Alterations, and Polycystic Ovaries.
Hai L; McGee SR; Rabideau AC; Paquet M; Narayan P
Biol Reprod; 2015 Jul; 93(1):16. PubMed ID: 26040673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]